Aarti Industries Ltd

Specialty Chemicals Segment (83% of revenues)^#
Under this segment, the Company has integrated operations across the benzene, sulphur and toluene product chains, and is ranked among the top three players globally for the manufacture of Nitro Chloro Benzenes (NCB) and Di-chloro Benzenes (DCB). The Company is also the only manufacturer of nitro fluoro aromatics using the Halex process and the only manufacturer of Phlyenediamines (PDA) value chain in India. Most of its speciality chemical products are primarily along the benzene-based value chain. Other chemicals such as sulphuric acid and its derivatives, single super phosphate, Toulene-based derivatives, calcium chloride granules, fuel additives and phthalates are also part of its manufacturing portfolio. ^#

Pharmaceuticals Segment (17% of revenues)
The company use its world-class expertise and modern manufacturing infrastructure to develop APIs, intermediates and xanthine derivatives for the pharmaceutical and food/beverages industry. It also has its own backward integrated intermediaries for most of the APIs that are manufactured. ^# API (Advanced Pharmaceutical Equipment) accounts for 61% of revenues of the segment and the Xanthine derivatives account for the rest 39% of revenues. ^#

Global Presence
The company has a global presence with exports around the world. Domestic (Indian) market accounts for 60% of total revenues, followed by Europe (14%), North America (9%), Japan (4%), China (3%) and rest of world accounts for the rest 10% of revenues. ^#

Client Base
The company has a client base of 700+ domestic clients and 400+ global clients. ^# Its clients belong to many industries viz. Pigments & Paints, Polymers, Agro intermediaries, Pharmaceuticals and others.
Its clients include Clariant, Sunchemical, Huntsman, Sudarshan, BASF, Toray, Bayer, UPL, Coromandel, Cipla, Sun Pharma, Lupin, Zydus, Dr. Reddy's, 3M, Dabur & many more. ^#

Limited Exposure
With a total of 200+ products in production ^#, the company has a diversified exposure to many industries. It has a 25-30% exposure in agro-chemicals, 25-30% in pharmaceuticals, 15-20% in polymers & additives, 15-20% in Dyes, Pigments and printing inks & 10-20% in FMCG, fuel additives and others. ^#

Manufacturing Facilities
The company has 13 manufacturing plants for its specialty chemicals division & 5 plants for its pharmaceuticals division. In total, it has 18 manufacturing facilities which are all located in western India with close proximity of ports for easy export. ^# Its manufacturing units are located in the states of Gujarat and Maharashtra. ^#
Out of 5 pharma plants, 2 plants are USFDA approved for manufacturing which makes it a preferred supplier of drugs. ^#
It also owns 6 co-gen power plants & a solar capacity of ~700 KW. ^#

Research & Development Capabilities
The company owns 4 R&D centres in India with a dedicated pool of 300+ engineers and scientists for developing customized products. ^# It operationalized Aarti Research & Technology Centre, its new R&D facility in Navi Mumbai in FY20. ^#